PLA2R1 and nephrotic syndrome: Interestingly, the serum obtained approximately half a year after biopsy showed definitive reactivity against NELL1 and PLA2R. Corticosteroid treatment was initiated as recommended in the Japanese guidelines [45], which improved the patient’s nephrotic syndrome.